Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016119522> ?p ?o ?g. }
- W2016119522 endingPage "92" @default.
- W2016119522 startingPage "84" @default.
- W2016119522 abstract "Background Cardiac disease is the leading cause of death in US prevalent hemodialysis (HD) patients. There is a lack of data about the impact of the severity of heart failure (HF) on outcomes and health-related quality of life (HRQoL) in HD patients. We aimed to determine the prognostic importance of the Index of Disease Severity (IDS) of the Index of Coexistent Disease (ICED) scoring system as an HF severity measure. Study Design Subanalysis of the Hemodialysis (HEMO) Study, a randomized controlled trial. Relationships between HF severity and mortality and cardiac hospitalizations were determined using Cox proportional hazards models. The relationship between HF severity and HRQoL scores was modeled using linear regression and generalized estimating equations. Setting & Participants 1,846 long-term HD patients at 15 clinical centers including 72 dialysis units. Predictor or Factor HF severity classified using the IDS of the ICED scoring system. Outcomes Mortality (all cause and cause specific), cardiac hospitalizations, and HRQoL. Measurements All-cause, cardiac, and infectious deaths; cardiac hospitalizations; and HRQoL scores from the Kidney Disease Quality of Life–Long Form. Results HF was present in 40% of HD patients. Increasing severity of HF was associated with older age, greater likelihood of diabetes, and lower serum albumin level (all P < 0.001). Adjusted HRs for all-cause mortality were 1.31 (95% CI, 1.12-1.53), 1.48 (95% CI, 1.19-1.85), and 2.11 (95% CI, 1.43-3.11) for mild, moderate, and severe HF, respectively (P < 0.001). All-cause, cardiac, and infectious mortality and cardiac hospitalizations increased with increasing severity of HF. Increasing HF severity was associated with decreases in HRQoL, particularly in physical functioning and sleep quality. Limitations This study is limited by the small sample size in the most severe HF group. Conclusions Increasing severity of HF is associated with increased mortality and cardiac hospitalizations and worse HRQoL, especially in perceived physical limitations. These findings emphasize the utility of the IDS of the ICED score as a valid prognostic tool for medical and HRQoL outcomes in the HD population with HF. Cardiac disease is the leading cause of death in US prevalent hemodialysis (HD) patients. There is a lack of data about the impact of the severity of heart failure (HF) on outcomes and health-related quality of life (HRQoL) in HD patients. We aimed to determine the prognostic importance of the Index of Disease Severity (IDS) of the Index of Coexistent Disease (ICED) scoring system as an HF severity measure. Subanalysis of the Hemodialysis (HEMO) Study, a randomized controlled trial. Relationships between HF severity and mortality and cardiac hospitalizations were determined using Cox proportional hazards models. The relationship between HF severity and HRQoL scores was modeled using linear regression and generalized estimating equations. 1,846 long-term HD patients at 15 clinical centers including 72 dialysis units. HF severity classified using the IDS of the ICED scoring system. Mortality (all cause and cause specific), cardiac hospitalizations, and HRQoL. All-cause, cardiac, and infectious deaths; cardiac hospitalizations; and HRQoL scores from the Kidney Disease Quality of Life–Long Form. HF was present in 40% of HD patients. Increasing severity of HF was associated with older age, greater likelihood of diabetes, and lower serum albumin level (all P < 0.001). Adjusted HRs for all-cause mortality were 1.31 (95% CI, 1.12-1.53), 1.48 (95% CI, 1.19-1.85), and 2.11 (95% CI, 1.43-3.11) for mild, moderate, and severe HF, respectively (P < 0.001). All-cause, cardiac, and infectious mortality and cardiac hospitalizations increased with increasing severity of HF. Increasing HF severity was associated with decreases in HRQoL, particularly in physical functioning and sleep quality. This study is limited by the small sample size in the most severe HF group. Increasing severity of HF is associated with increased mortality and cardiac hospitalizations and worse HRQoL, especially in perceived physical limitations. These findings emphasize the utility of the IDS of the ICED score as a valid prognostic tool for medical and HRQoL outcomes in the HD population with HF." @default.
- W2016119522 created "2016-06-24" @default.
- W2016119522 creator A5036610114 @default.
- W2016119522 creator A5042028982 @default.
- W2016119522 creator A5043993000 @default.
- W2016119522 creator A5079195586 @default.
- W2016119522 creator A5082886161 @default.
- W2016119522 creator A5088597883 @default.
- W2016119522 creator A5089217875 @default.
- W2016119522 date "2011-07-01" @default.
- W2016119522 modified "2023-09-25" @default.
- W2016119522 title "Heart Failure Severity Scoring System and Medical- and Health-Related Quality-of-Life Outcomes: The HEMO Study" @default.
- W2016119522 cites W1493773294 @default.
- W2016119522 cites W1557485531 @default.
- W2016119522 cites W1700484054 @default.
- W2016119522 cites W1967653075 @default.
- W2016119522 cites W1968668632 @default.
- W2016119522 cites W1971260166 @default.
- W2016119522 cites W1975441982 @default.
- W2016119522 cites W1978732253 @default.
- W2016119522 cites W1984749646 @default.
- W2016119522 cites W1990281273 @default.
- W2016119522 cites W1994662257 @default.
- W2016119522 cites W1998207473 @default.
- W2016119522 cites W2013544899 @default.
- W2016119522 cites W2014031872 @default.
- W2016119522 cites W2019909593 @default.
- W2016119522 cites W2025589168 @default.
- W2016119522 cites W2025939340 @default.
- W2016119522 cites W2027109868 @default.
- W2016119522 cites W2028786992 @default.
- W2016119522 cites W2029724069 @default.
- W2016119522 cites W2030038103 @default.
- W2016119522 cites W2030069905 @default.
- W2016119522 cites W2034480779 @default.
- W2016119522 cites W2036761751 @default.
- W2016119522 cites W2037377025 @default.
- W2016119522 cites W2044351705 @default.
- W2016119522 cites W2044739061 @default.
- W2016119522 cites W2046644339 @default.
- W2016119522 cites W2047185386 @default.
- W2016119522 cites W2070309439 @default.
- W2016119522 cites W2075442705 @default.
- W2016119522 cites W2075536991 @default.
- W2016119522 cites W2077740525 @default.
- W2016119522 cites W2085278427 @default.
- W2016119522 cites W2100269530 @default.
- W2016119522 cites W2108899468 @default.
- W2016119522 cites W2109712401 @default.
- W2016119522 cites W2117468977 @default.
- W2016119522 cites W2137197828 @default.
- W2016119522 cites W2318806041 @default.
- W2016119522 cites W2323955419 @default.
- W2016119522 cites W2324197900 @default.
- W2016119522 cites W2328140092 @default.
- W2016119522 cites W2333262619 @default.
- W2016119522 cites W2341452993 @default.
- W2016119522 cites W3152220265 @default.
- W2016119522 cites W614531583 @default.
- W2016119522 doi "https://doi.org/10.1053/j.ajkd.2011.01.029" @default.
- W2016119522 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4508008" @default.
- W2016119522 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21549465" @default.
- W2016119522 hasPublicationYear "2011" @default.
- W2016119522 type Work @default.
- W2016119522 sameAs 2016119522 @default.
- W2016119522 citedByCount "7" @default.
- W2016119522 countsByYear W20161195222015 @default.
- W2016119522 countsByYear W20161195222016 @default.
- W2016119522 countsByYear W20161195222017 @default.
- W2016119522 countsByYear W20161195222019 @default.
- W2016119522 countsByYear W20161195222020 @default.
- W2016119522 countsByYear W20161195222021 @default.
- W2016119522 countsByYear W20161195222023 @default.
- W2016119522 crossrefType "journal-article" @default.
- W2016119522 hasAuthorship W2016119522A5036610114 @default.
- W2016119522 hasAuthorship W2016119522A5042028982 @default.
- W2016119522 hasAuthorship W2016119522A5043993000 @default.
- W2016119522 hasAuthorship W2016119522A5079195586 @default.
- W2016119522 hasAuthorship W2016119522A5082886161 @default.
- W2016119522 hasAuthorship W2016119522A5088597883 @default.
- W2016119522 hasAuthorship W2016119522A5089217875 @default.
- W2016119522 hasBestOaLocation W20161195222 @default.
- W2016119522 hasConcept C126322002 @default.
- W2016119522 hasConcept C134018914 @default.
- W2016119522 hasConcept C159110408 @default.
- W2016119522 hasConcept C177713679 @default.
- W2016119522 hasConcept C2778063415 @default.
- W2016119522 hasConcept C2778198053 @default.
- W2016119522 hasConcept C2778653478 @default.
- W2016119522 hasConcept C2779134260 @default.
- W2016119522 hasConcept C2779951463 @default.
- W2016119522 hasConcept C2779978075 @default.
- W2016119522 hasConcept C30036603 @default.
- W2016119522 hasConcept C50382708 @default.
- W2016119522 hasConcept C555293320 @default.
- W2016119522 hasConcept C71924100 @default.
- W2016119522 hasConceptScore W2016119522C126322002 @default.
- W2016119522 hasConceptScore W2016119522C134018914 @default.